NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.41
-0.61 (-3.81%)
Nov 16, 2026, 4:00 PM EST - Market closed
NeoGenomics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NeoGenomics stock has a consensus rating of "Buy" and an average price target of $23.4. The average 1-year stock price forecast is 51.85% higher than the current stock price, while the lowest is $19 (+23.30%) and the highest is $35 (+127.13%).
Price Target: $23.4 (+51.85%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 29, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $19 → $23 | Buy | Maintains | $19 → $23 | +49.25% | Oct 29, 2026 |
| Jefferies | Jefferies | Buy Maintains $17 → $21 | Buy | Maintains | $17 → $21 | +36.28% | Oct 29, 2026 |
| Needham | Needham | Buy Reiterates $22 | Buy | Reiterates | $22 | +42.76% | Oct 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $35 | Buy | Reiterates | $35 | +127.13% | Oct 29, 2026 |
Financial Forecast
Revenue This Year
808.21M
from 727.33M
Increased by 11.12%
Revenue Next Year
886.46M
from 808.21M
Increased by 9.68%
EPS This Year
0.20
from 0.12
Increased by 69.17%
EPS Next Year
0.34
from 0.20
Increased by 67.49%
EPS and Forward PE are based on non-GAAP adjusted numbers.